Skip to main content
. 2022 Jun 8;6(1):117–141. doi: 10.5334/cpsy.85

Table 7.

Model-Free Task Measures by Group and Session (Means and Standard Deviations).


FULL SAMPLE

TOTAL BASELINE FOLLOW-UP USABLE DATA (N) EFFECT OF CLINICAL STATUS EFFECT OF SESSION EFFECT OF CLINICAL STATUS/SESSION INTERACTION


HCS SUDS HCS SUDS


131 48 83 48 83

Wins 181.1 (12.71) 182.83 (12.19) 178.75 (12.79) 182.27 (12.14) 181.78 (13.12) HC: 45
 SUD +: 77
Total: 122
F(1, 117) = 1.97
p = 0.16
η2 = 0.02
F(1, 120) = 1.33
p = 0.25
η2 = 0.01
F(1, 120) = 0.74
p = 0.39
η2 = 0.01

Mean Reaction Time 0.56 (0.25) 0.62 (0.24) 0.61 (0.27) 0.53 (0.23) 0.5 (0.22) HC: 45
 SUD +: 77
Total: 122
F(1, 117) = 3.46
p = 0.07
η2 = 0.03
F(1, 120) = 29.56
p < 0.001
η2 = 0.2
F(1, 120) = 0.6
p = 0.44
η2 = 0.01

Win/Stay 134.28 (33.91) 133.5 (32.91) 131.63 (36.63) 131.21 (31.49) 139.17 (33.03) HC: 45
 SUD +: 77
Total: 122
F(1, 117) = 0.27
p = 0.6
η2 = 0
F(1, 120) = 2.61
p = 0.11
η2 = 0.02
F(1, 120) = 1.99
p = 0.16
η2 = 0.02

Win/Shift 35.08 (28.17) 37.88 (28.11) 35.46 (29.6) 39.06 (25.85) 30.8 (27.94) HC: 45
 SUD +: 77
Total: 122
F(1, 117) = 1.42
p = 0.24
η2 = 0.01
F(1, 120) = 2.15
p = 0.15
η2 = 0.02
F(1, 120) = 1.24
p = 0.27
η2 = 0.01

Lose/Stay 47.11 (29.45) 39.33 (25.51) 46.42 (30.11) 45.98 (24.45) 52.96 (32.66) HC: 45
 SUD +: 77
Total: 122
F(1, 117) = 7.21
p = 0.008
η2 = 0.06
F(1, 120) = 9.16
p = 0.003
η2 = 0.07
F(1, 120) = 0.06
p = 0.8
η2 = 0

Lose/Shift 83.52 (30.99) 89.29 (27.39) 86.49 (32.07) 83.75 (27.07) 77.07 (33.27) HC: 45
 SUD +: 77
Total: 122
F(1, 117) = 4.08
p = 0.05
η2 = 0.03
F(1, 120) = 12.7
p < 0.001
η2 = 0.1
F(1, 120) = 0.79
p = 0.38
η2 = 0.01

PROPENSITY-MATCHED

TOTAL BASELINE FOLLOW-UP USABLE DATA (N) EFFECT OF CLINICAL STATUS EFFECT OF SESSION EFFECT OF CLINICAL STATUS/SESSION INTERACTION


HCS SUDS HCS SUDS


70 45 25 45 25

Wins 180.76 (12.56) 182.4 (12.46) 177.92 (11.15) 182.44 (11.95) 177.64 (14.65) HC: 45
 SUD +: 25
Total: 70
F(1, 65) = 3.44
p = 0.07
η2 = 0.05
F(1, 68) = 0
p = 0.97
η2 = 0
F(1, 68) = 0.01
p = 0.93
η2 = 0

Mean Reaction Time 0.55 (0.23) 0.62 (0.25) 0.57 (0.21) 0.53 (0.23) 0.47 (0.17) HC: 45
 SUD +: 25
Total: 70
F(1, 65) = 1.87
p = 0.18
η2 = 0.03
F(1, 68) = 14.39
p < 0.001
η2 = 0.17
F(1, 68) = 0.04
p = 0.85
η2 = 0

Win/Stay 132.44 (32.63) 132.96 (33.22) 129.64 (38.41) 132.24 (32.13) 134.68 (27.58) HC: 45
 SUD +: 25
Total: 70
F(1, 65) = 0
p = 0.97
η2 = 0
F(1, 68) = 0.09
p = 0.76
η2 = 0
F(1, 68) = 0.39
p = 0.54
η2 = 0.01

Win/Shift 36.78 (27.93) 38.11 (28.05) 37.04 (33.09) 38.09 (26.38) 31.76 (25.9) HC: 45
 SUD +: 25
Total: 70
F(1, 65) = 0.46
p = 0.5
η2 = 0.01
F(1, 68) = 0.28
p = 0.6
η2 = 0
F(1, 68) = 0.49
p = 0.49
η2 = 0.01

Lose/Stay 46.19 (29.26) 38.31 (25.88) 51 (30.01) 45.22 (24.7) 57.32 (37.94) HC: 45
 SUD +: 25
Total: 70
F(1, 65) = 4.56
p = 0.04
η2 = 0.07
F(1, 68) = 3.97
p = 0.05
η2 = 0.06
F(1, 68) = 0.01
p = 0.93
η2 = 0

Lose/Shift 84.59 (29.69) 90.62 (27.71) 82.32 (32.22) 84.44 (27.78) 76.24 (33.13) HC: 45
 SUD +: 25
Total: 70
F(1, 65) = 2.04
p = 0.16
η2 = 0.03
F(1, 68) = 3.13
p = 0.08
η2 = 0.04
F(1, 68) = 0
p = 0.99
η2 = 0

* Analyses are reported using results from LMEs accounting for age, sex, and premorbid IQ (WRAT). Significant effects are bolded.